According to new reports, physicians and researchers are reviewing the psychotropic ingredient found in mushrooms for their role in easing anxiety at the end of life.  Learn more in this article from McKnight’s Long-Term Care News.

Federal regulators nixed most legitimate clinical research on hallucinogens after the counter-culture movement of the 1960s embraced the use of the drugs as part of their anti-establishment activities. Now, under very controlled circumstances, researchers are once again examining their possible use in helping to treat depression and anxiety, especially among hospice patients at the end of life, The New York Times reported recently.

Click here for full article: